14158 Results (Page 42 of 567)
All Market Research Reports
Egypt Home Infusion Therapy Market
The Egypt Home Infusion Therapy Market was valued at $100.7 Mn in 2023 and is predicted to grow at a CAGR of 9.6% from 2023 to 2030, to $191.3 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the Egypt Home Infusion Therapy Market are SA Homecare, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
Vietnam Home Infusion Therapy Market
The Vietnam Home Infusion Therapy Market was valued at $179.8 Mn in 2023 and is predicted to grow at a CAGR of 8.33% from 2023 to 2030, to $314.8 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the Vietnam Home Infusion Therapy Market are QMed Asia, Terumo Corporation, Nipro Corporation, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
Singapore Home Infusion Therapy Market
The Singapore Home Infusion Therapy Market was valued at $43.2 Mn in 2023 and is predicted to grow at a CAGR of 8.7% from 2023 to 2030, to $77.4 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the Singapore Home Infusion Therapy Market are Terumo Corporation, Nipro Corporation, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
Philippines Home Infusion Therapy Market
The Philippines Home Infusion Therapy Market was valued at $79.1 Mn in 2023 and is predicted to grow at a CAGR of 8.6% from 2023 to 2030, to $140.9 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the Philippines Home Infusion Therapy Market are Terumo Corporation, Nipro Corporation, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
Malaysia Home Infusion Therapy Market
The Malaysia Home Infusion Therapy Market was valued at $57.8 Mn in 2023 and is predicted to grow at a CAGR of 8.3% from 2023 to 2030, to $101 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the Malaysia Home Infusion Therapy Market are QMed Asia, Terumo Corporation, Nipro Corporation, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
Japan Home Infusion Therapy Market
The Japan Home Infusion Therapy Market was valued at $2235.2 Mn in 2023 and is predicted to grow at a CAGR of 8.6% from 2023 to 2030, to $3982.3 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the Japan Home Infusion Therapy Market are Terumo Corporation, Nipro Corporation, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
Indonesia Home Infusion Therapy Market
The Indonesia Home Infusion Therapy Market was valued at $215.8 Mn in 2023 and is predicted to grow at a CAGR of 8.1% from 2023 to 2030, to $372.2 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the Indonesia Home Infusion Therapy Market are Terumo Corporation, Nipro Corporation, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
China Home Infusion Therapy Market
The China Home Infusion Therapy Market was valued at $2890.7 Mn in 2023 and is predicted to grow at a CAGR of 9.6% from 2023 to 2030, to $5491.4 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the China Home Infusion Therapy Market are Poly Medicure, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
UK Home Infusion Therapy Market
The UK Home Infusion Therapy Market was valued at $935 Mn in 2023 and is predicted to grow at a CAGR of 6.1% from 2023 to 2030, to $1415.1 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the UK Home Infusion Therapy Market are Becton, Dickinson and Company (BD), Baxter International, ICU Medical (Smiths Medical), and Fresenius Kabi, among others.
Spain Home Infusion Therapy Market
The Spain Home Infusion Therapy Market was valued at $694 Mn in 2023 and is predicted to grow at a CAGR of 7.1% from 2023 to 2030, to $1121.8 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the Spain Home Infusion Therapy Market are Becton, Dickinson and Company (BD), Baxter International, ICU Medical (Smiths Medical), and Fresenius Kabi, among others.
Germany Home Infusion Therapy Market
The Germany Home Infusion Therapy Market was valued at $1316.1 Mn in 2023 and is predicted to grow at a CAGR of 6.3% from 2023 to 2030, to $2018.5 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the Germany Home Infusion Therapy Market are Option Care Health, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
France Home Infusion Therapy Market
The France Home Infusion Therapy Market was valued at $988.9 Mn in 2023 and is predicted to grow at a CAGR of 7.1% from 2023 to 2030, to $1598.4 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the France Home Infusion Therapy Market are Option Care Health, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
Mexico Home Infusion Therapy Market
The Mexico Home Infusion Therapy Market was valued at $539.4 Mn in 2023 and is predicted to grow at a CAGR of 8.35% from 2023 to 2030, to $945.6 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the Mexico Home Infusion Therapy Market are Option Care Health, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
Brazil Home Infusion Therapy Market
The Brazil Home Infusion Therapy Market was valued at $899 Mn in 2023 and is predicted to grow at a CAGR of 9.1% from 2023 to 2030, to $1654 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the Brazil Home Infusion Therapy Market are Poly Medicure, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
UAE Home Infusion Therapy Market
The UAE Home Infusion Therapy Market was valued at $179.8 Mn in 2023 and is predicted to grow at a CAGR of 9.1% from 2023 to 2030, to $330.8 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the UAE Home Infusion Therapy Market are Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
Saudi Arabia Home Infusion Therapy Market
The Saudi Arabia Home Infusion Therapy Market was valued at $611.3 Mn in 2023 and is predicted to grow at a CAGR of 9.6% from 2023 to 2030, to $1161.3 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the Saudi Arabia Home Infusion Therapy Market are Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
US Home Infusion Therapy Market
The US Home Infusion Therapy Market was valued at $15103.2 Mn in 2023 and is predicted to grow at a CAGR of 6.1% from 2023 to 2030, to $22860 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the US Home Infusion Therapy Market are Option Care Health, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
Canada Home Infusion Therapy Market
The Canada Home Infusion Therapy Market was valued at $2876.8 Mn in 2023 and is predicted to grow at a CAGR of 8.1% from 2023 to 2030, to $4962.4 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the Canada Home Infusion Therapy Market are Option Care Health, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
South Africa Hepatitis A Therapeutics Market Analysis
The South Africa Hepatitis A Therapeutics Market was valued at $4.79 Mn in 2023 and is predicted to grow at a CAGR of 3.43% from 2023 to 2030 to $6.07 Mn by 2030. Factors driving this expansion include the prevalence of Hepatitis A, increasing healthcare expenditure, and challenges related to water and sanitation. Key players such as Sanofi and Walgreens Boots Alliance (WBA) play crucial roles in this sector's development.
Kenya Hepatitis A Therapeutics Market Analysis
The Kenya Hepatitis A Therapeutics Market was valued at $0.52 Mn in 2023 and is predicted to grow at a CAGR of 3.3% from 2023 to 2030 to $0.65 Mn by 2030. Key factors propelling this market include poor sanitation, contaminated water sources, and a lack of immunity, which drives demand for Hepatitis A therapeutics. Notable contributors to this sector include Zydus Cadilla and Merck & Co. Inc.
Egypt Hepatitis A Therapeutics Market Analysis
The Egypt Hepatitis A Therapeutics Market was valued at $2.06 Mn in 2023 and is predicted to grow at a CAGR of 3.7% from 2023 to 2030 to $2.66 Mn by 2030. Key drivers of this market include the rise in disease prevalence, increasing disposable incomes, and improved access to healthcare. Prominent companies in this market include Merck & Co. Inc. and Sanofi, among others.
Vietnam Hepatitis A Therapeutics Market Analysis
The Vietnam Hepatitis A Therapeutics Market was valued at $3.69 Mn in 2023 and is predicted to grow at a CAGR of 2.43% from 2023 to 2030 to $4.36 Mn by 2030. This expansion is mainly fuelled by supportive government initiatives and healthcare expenditure, economic growth, and rising travel and tourism. Leading companies in this market include GSK and F. Hoffmann-La Roche Ltd., among others.
Singapore Hepatitis A Therapeutics Market Analysis
The Singapore Hepatitis A Therapeutics Market was valued at $0.88 Mn in 2023 and is predicted to grow at a CAGR of 2.8% from 2023 to 2030 to $1.07 Mn by 2030. Key drivers of this growth include advancements in vaccines, shifting epidemiology, and travel-related Hepatitis A cases in Singapore. Major players in this market segment include Takeda and F. Hoffmann-La Roche Ltd., among others.
Philippines Hepatitis A Therapeutics Market Analysis
The Philippine Hepatitis A Therapeutics Market was valued at $1.62 Mn in 2023 and is predicted to grow at a CAGR of 2.7% from 2023 to 2030 to $1.95 Mn by 2030. The market is primarily driven by low immunization rates, supportive government initiatives, the decentralization of health services, increased local government authority, and the universal health coverage (UHC) Law. Leading companies in this field include Abbott Laboratories and Sanofi, among others.
Malaysia Hepatitis A Therapeutics Market Analysis
The Malaysia Hepatitis A Therapeutics Market was valued at $1.19 Mn in 2023 and is predicted to grow at a CAGR of 2.2% from 2023 to 2030 to $1.40 Mn by 2030. Key drivers fuelling this market include the increasing prevalence of Hepatitis A, poor sanitation and hygiene practices, and lack of immunity among younger demographics. Pharmaniaga and F. Hoffmann-La Roche Ltd. are among the prominent companies contributing significantly to this sector.
